Mayzent and Daydreaming - a phase IV clinical study of FDA data


Daydreaming is reported only by a few people who take Mayzent.

The phase IV clinical study analyzes which people take Mayzent and have Daydreaming. It is created by eHealthMe based on reports of 7,239 people who have side effects while taking Mayzent from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 02, 2022

7,239 people reported to have side effects when taking Mayzent.
Among them, 4 people (0.06%) have Daydreaming.

What is Mayzent?

Mayzent has active ingredients of siponimod fumaric acid. eHealthMe is studying from 7,240 Mayzent users for its effectiveness, alternative drugs and more.

What is Daydreaming?

Daydreaming is found to be associated with 725 drugs and 598 conditions by eHealthMe.

Number of Mayzent and Daydreaming reports submitted per year:

Could Mayzent cause Daydreaming?

Gender of people who have Daydreaming when taking Mayzent *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Daydreaming when taking Mayzent *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

Common drugs people take besides Mayzent *:

  1. Melatonin: 1 person, 25.00%
  2. Aubagio: 1 person, 25.00%

Common side effects people have besides Daydreaming *:

  1. Memory Loss: 4 people, 100.00%
  2. Balance Disorder: 2 people, 50.00%
  3. Feeling Abnormal: 2 people, 50.00%
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 50.00%
  5. Pain: 2 people, 50.00%
  6. Breathing Difficulty: 1 person, 25.00%
  7. Burning Sensation: 1 person, 25.00%
  8. Chest Pain: 1 person, 25.00%
  9. Cough: 1 person, 25.00%
  10. Fatigue (feeling of tiredness): 1 person, 25.00%

Common conditions people have *:

  1. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 50.00%
  2. Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 1 person, 25.00%
  3. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 25.00%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 25.00%
  5. Clinically Isolated Syndrome (individual's first neurological episode, caused by inflammation or demyelination of nerve tissue): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mayzent and have Daydreaming?

Check whether Daydreaming is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Daydreaming and when was it recovered:

Expand to all the drugs that have ingredients of siponimod fumaric acid:

Alternative drugs to, pros and cons of Mayzent:

Common Mayzent side effects:

Browse all side effects of Mayzent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Daydreaming treatments and more:

COVID vaccines that are related to Daydreaming:

Common drugs associated with Daydreaming:

All the drugs that are associated with Daydreaming:

All the conditions that are associated with Daydreaming:

How the study uses the data?

The study uses data from the FDA. It is based on siponimod fumaric acid (the active ingredients of Mayzent) and Mayzent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: